Barrington lowered the firm’s price target on Cimpress (CMPR) to $95 from $119 and keeps an Outperform rating on the shares following the fiscal Q2 report. Management believes the disappointing results were due to short-term factors, and the company remains confident in its favorable long-term outlook, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio